Receptor for AGE (RAGE) Mediates Neointimal Formation in Response to Arterial Injury

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Circulation

• Publication date

  2003-05-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000063577.32819.23PMID 12719284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses

  2002cited by this paper
• Effects of Balloon Injury on Neointimal Hyperplasia in Streptozotocin-Induced Diabetes and in Hyperinsulinemic Nondiabetic Pancreatic Islet–Transplanted Rats

  2001cited by this paper
• Neointimal Hyperplasia After Arterial Injury Is Increased in a Rat Model of Non–Insulin-Dependent Diabetes Mellitus

  2001cited by this paper
• Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration.

  2001cited by this paper
• Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways*

  1999cited by this paper
• RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

  1999cited by this paper
• Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

  1998cited by this paper
• Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement.

  1998cited by this paper
• Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress*

  1997cited by this paper
• Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.

  1997cited by this paper
• Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study.

  1997cited by this paper
• Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products*

  1997cited by this paper
• The Receptor for Advanced Glycation End Products Mediates the Chemotaxis of Rabbit Smooth Muscle Cells

  1997cited by this paper
• Advanced glycation end products, oxidant stress and vascular lesions

  1997cited by this paper
• Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.

  1996cited by this paper
• The cellular and molecular mechanisms of diabetic complications.

  1996cited by this paper
• The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.

  1996cited by this paper
• Advanced glycation endproducts-receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet-derived growth factor-B.

  1996cited by this paper
• Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.

  1995cited by this paper
• Advanced protein glycosylation in diabetes and aging.

  1995cited by this paper
• Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease.

  1995cited by this paper
• Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

  1994cited by this paper
• Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

  1993cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

  1984cited by this paper
• Response of the Aorta of the Obese Zucker Rat to Injury

  1981cited by this paper
• Rapid Publication

  1971cited by this paper
• Blockade of RAGE ± amphoterin signalling suppresses tumour growth and metastases

  year unknowncited by this paper

• The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population

  2024cites this paper
• Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials

  2024cites this paper
• Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy

  2023cites this paper
• Cardiovascular disease in type 1 diabetes, an underestimated danger: Epidemiological and pathophysiological data.

  2023cites this paper
• Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study

  2022cites this paper
• Mechanism of Hypercholesterolemia-Induced Atherosclerosis

  2022cites this paper
• Does AGE-RAGE Stress Play a Role in the Development of Coronary Artery Disease in Obesity?

  2022cites this paper
• HIV-1 Tat Upregulates the Receptor for Advanced Glycation End Products and Superoxide Dismutase-2 in the Heart of Transgenic Mice

  2022cites this paper
• Effects of RAGE Deletion on the Cardiac Transcriptome during Aging

  2022cites this paper
• AGE–RAGE Stress and Coronary Artery Disease

  2021cites this paper
• Satellite Cell Expression of RAGE (Receptor for Advanced Glycation end Products) Is Important for Collateral Vessel Formation

  2021cites this paper
• Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis

  2021cites this paper
• The relationship between endogenous secretory RAGE and cardiac autonomic function in prediabetes

  2021cites this paper
• Satellite Cell Expression of RAGE is Important for Collateral Vessel Formation

  2021cites this paper
• Mitochondrial Dysfunction: Cause or Consequence of Vascular Calcification?

  2021cites this paper
• AGE-RAGE Axis in the Pathophysiology of Chronic Lower Limb Ischemia and a Novel Strategy for Its Treatment

  2020cites this paper
• Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms

  2020cites this paper
• Vitamin D attenuates HMGB1-mediated neointimal hyperplasia after percutaneous coronary intervention in swine

  2020cites this paper
• High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality

  2019cites this paper
• The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.

  2019cites this paper
• Diabetes and Stroke: The Role of Glucose Regulation

  2019cites this paper
• High mobility group protein B1 (HMGB1) interacts with receptor for advanced glycation end products (RAGE) to promote airway smooth muscle cell proliferation through ERK and NF-κB pathways.

  2019cites this paper
• The receptor for advanced glycation end products is a critical mediator of type 2 cytokine signaling in the lungs.

  2019cites this paper
• Catalpol ameliorates advanced glycation end product‐induced dysfunction of glomerular endothelial cells via regulating nitric oxide synthesis by inducible nitric oxide synthase and endothelial nitric oxide synthase

  2019cites this paper
• The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function

  2018cites this paper
• Effect of Aggressive lipid-lowering treatment with Rosuvastatin on vascular endoTHelium function: evaluation of vascular endothelium function (EARTH study)

  2018cites this paper
• Murine models of vascular endothelial injury: Techniques and pathophysiology.

  2018cites this paper
• Advanced Glycation End Products:Receptors for Advanced Glycation End Products Axis in Coronary Stent Restenosis: A Prospective Study

  2018cites this paper
• Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis

  2018cites this paper
• Chapter 3 Dietary Recommendations for Patients with Cardiovascular Disease and Diabetes

  2018cites this paper
• Ginsenoside Rg3 stereoisomers differentially inhibit vascular smooth muscle cell proliferation and migration in diabetic atherosclerosis

  2018cites this paper
• Fluvastatin inhibits advanced glycation end products-induced proliferation, migration, and extracellular matrix accumulation in vascular smooth muscle cells by targeting connective tissue growth factor

  2018cites this paper
• Advanced glycation end products promote the proliferation and migration of primary rat vascular smooth muscle cells via the upregulation of BAG3

  2017cites this paper
• Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells

  2017cites this paper
• Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension

  2017cites this paper
• AGE–RAGE Stress, Stressors, and Antistressors in Health and Disease

  2017cites this paper
• S100B promotes injury-induced vascular remodeling through modulating smooth muscle phenotype.

  2017cites this paper
• Health Status Improved by Aronia Melanocarpa Polyphenolic Extract

  2017cites this paper
• Dietary Recommendations for Patients with Cardiovascular Disease and Diabetes

  2017cites this paper
• The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice

  2016cites this paper
• Endothelial IGF-1 Receptor Signalling in Diabetes and Insulin Resistance.

  2016cites this paper
• The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk.

  2016cites this paper
• Atherosclerosis and the Hypercholesterolemic AGE–RAGE Axis

  2016cites this paper
• [Level of Soluble Receptor for Glycation End-Products in Patients With Restenosis After Coronary Artery Stenting].

  2016cites this paper
• A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics.

  2016cites this paper
• Inflammation in Ischemic Heart Disease

  2015cites this paper
• Pathophysiology and Medical Treatment of Carotid Artery Stenosis

  2015cites this paper
• Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up

  2015cites this paper
• Inflammation in Ischemic Heart Disease

  2015cites this paper
• Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali

  2014cites this paper
• Erythropoietin Upregulation in Pulmonary Arterial Hypertension

  2014cites this paper
• GeneOptimizer program-assisted cDNA reengineering enhances sRAGE autologous expression in Chinese hamster ovary cells.

  2014cites this paper
• Vessel Ultrasound Sonographic Assessment of Soluble Receptor for Advanced Glycation End Products Efficacy in a Rat Balloon Injury Model

  2014cites this paper
• Glycation: the angiogenic paradox in aging and age-related disorders and diseases.

  2014cites this paper
• Endothelial dysfunction in metabolic diseases: role of oxidation and possible therapeutic employment of N-acetylcysteine.

  2014cites this paper
• Increase of ADAM10 Level in Coronary Artery In-Stent Restenosis Segments in Diabetic Minipigs: High ADAM10 Expression Promoting Growth and Migration in Human Vascular Smooth Muscle Cells via Notch 1 and 3

  2013cites this paper
• The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth

  2013influential citation
• The Glycoform Modifications of sRAGE Matter

  2013cites this paper
• Exendin-4 and GLP-1 decreases induced expression of ICAM-1, VCAM-1 and RAGE in human retinal pigment epithelial cells

  2013cites this paper
• Do statins have a role in reduction/prevention of post-PCI restenosis?

  2013cites this paper
• RAGE regulation and signaling in inflammation and beyond

  2013cites this paper
• Glycated matrix up-regulates inflammatory signaling similarly to Porphyromonas gingivalis lipopolysaccharide.

  2013cites this paper
• The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?

  2013cites this paper
• Novel pathways and therapies in experimental diabetic atherosclerosis

  2012cites this paper
• Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress.

  2012cites this paper
• Novel pathways and therapies in experimental diabetic

  2012cites this paper
• RAGE Mediates Accelerated Diabetic Vein Graft Atherosclerosis Induced by Combined Mechanical Stress and AGEs via Synergistic ERK Activation

  2012cites this paper
• Advanced Glycation Endproduct Crosslinking in the Cardiovascular System

  2012cites this paper
• RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity.

  2012cites this paper
• Detecting DNA synthesis of neointimal formation after catheter balloon injury in GK and in Wistar rats: using 5-ethynyl-2'-deoxyuridine

  2012cites this paper
• Resveratrol, Wine, and Atherosclerosis

  2012cites this paper
• Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling

  2012cites this paper
• Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative and Signal Transduction Pathways

  2012cites this paper
• Grape Seed Procyanidin B2 Inhibits Human Aortic Smooth Muscle Cell Proliferation and Migration Induced by Advanced Glycation End Products

  2011cites this paper
• RAGE and cardiovascular disease.

  2011cites this paper
• Cardiovascular Complications in Renal Failure: Implications of Advanced Glycation End Products and Their Receptor RAGE

  2011cites this paper
• RAGE biology, atherosclerosis and diabetes.

  2011cites this paper
• Soluble receptor for advanced glycation end products is associated with in-stent restenosis in patients with type 2 diabetes with drug-eluting coronary stents

  2011cites this paper
• Inhibition of reactive oxygen species/extracellular signal-regulated kinases pathway by pioglitazone attenuates advanced glycation end products-induced proliferation of vascular smooth muscle cells in rats.

  2011cites this paper
• Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration.

  2011cites this paper
• Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice

  2011cites this paper
• Effect of metabolic syndrome on the response to arterial injury.

  2011cites this paper
• RAGE-Dependent Activation of the Oncoprotein Pim1 Plays a Critical Role in Systemic Vascular Remodeling Processes

  2011cites this paper
• Phytoestrogen calycosin‐7‐O‐β‐D‐glucopyranoside ameliorates advanced glycation end products‐induced HUVEC damage

  2011cites this paper
• The Role of the Receptor for Advanced Glycation End-Products in a Murine Model of Silicosis

  2010cites this paper
• Advanced glycation end‐products and the kidney

  2010cites this paper
• Molecular mechanisms of diabetic vascular complications

  2010cites this paper
• S100A12 Mediates Aortic Wall Remodeling and Aortic Aneurysm

  2010cites this paper
• Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictor of Restenosis Following Percutaneous Coronary Intervention

  2010cites this paper
• Animal models for studying neointima formation.

  2010cites this paper
• S100B Interaction With the Receptor for Advanced Glycation End Products (RAGE): A Novel Receptor-Mediated Mechanism for Myocyte Apoptosis Postinfarction

  2010cites this paper
• Molecular dissection of Porphyromonas gingivalis-related arteriosclerosis: a novel mechanism of vascular disease.

  2010cites this paper
• ANTI-AGE ANTIBODIES AND MARKERS OF OXIDATIVE STRESS IN SPONTANEOUSLY HYPERTENSIVE RATS AT DIFFERENT AGES

  2010cites this paper
• Blockade of PKC-beta protects HUVEC from advanced glycation end products induced inflammation.

  2010cites this paper
• AGE-RAGE signalling in endothelial dysfunction and atherosclerosis in diabetes

  2010cites this paper
• Utilidad de los biomarcadores plasmáticos en el diagnóstico, tratamiento y pronóstico de la enfermedad cerebrovascular aguda

  2010cites this paper
• Endothelial Dysfunction and Inflammation

  2010cites this paper
• Alagebrium Chloride, a Novel Advanced Glycation End-Product Cross Linkage Breaker, Inhibits Neointimal Proliferation in a Diabetic Rat Carotid Balloon Injury Model

  2010cites this paper
• Blockade of renin-angiotensin system attenuates advanced glycation end products-mediated signaling pathways.

  2010cites this paper
• Advanced glycation end products and C-peptide—modulators in diabetic vasculopathy and atherogenesis

  2009cites this paper